Ultraviolet irradiation- and dimethyl sulfoxide-induced telomerase activity in ovarian epithelial cell lines

被引:18
作者
Alfonso-De Matte, MY
Cheng, JQ
Kruk, PA
机构
[1] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
关键词
telomerase; ovarian cancer; UV irradiation; hTRT; PI; 3-kinase; dimethyl sulfoxide; wortmannin; LY294002; hTR; cycloheximide;
D O I
10.1006/excr.2001.5231
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Information about telomerase regulation is incomplete, especially since various studies suggest complexity in telomerase regulation. Given the important association between telomerase and cancer, it is imperative to design and develop a model system in which telomerase activity can be regulated and studied. We employed ultraviolet (UV radiation or dimethyl sulfoxide (DMSO) to transiently induce telomerase activity in a telomerase-positive cell line and, most importantly, in a telomerase-negative cell line. UV- or DMSO-induced telomerase activity was associated with increased hTRT, but not hTR, mRNA transcription in the telomerase-negative cells. However, no changes in hTRT or hTR mRNA transcription were noted with UV- or DMSO-induced telomerase activity in the telomerase-positive cells. Inhibition of protein synthesis or the phosphotidyl inositol 3-kinase (PI3K) pathway suppressed telomerase induction and/or activity in all cell lines examined, suggesting telomerase activity was dependent on protein synthesis and PI3K-mediated phosphorylation. Furthermore, enhanced telomerase activity was limited to UV and DMSO, since a variety of chemotherapeutic agents failed to induce telomerase activity. Therefore, our data provide a useful culture model system to study telomerase regulation in telomerase-negative and -positive cell lines and from which to obtain information about telomerase as a target for cancer intervention. (C) 2001 Academic Press.
引用
收藏
页码:13 / 27
页数:15
相关论文
共 79 条
[71]  
Wan YS, 2001, INT J ONCOL, V18, P461
[72]   Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT [J].
Weinrich, SL ;
Pruzan, R ;
Ma, LB ;
Ouellette, M ;
Tesmer, VM ;
Holt, SE ;
Bodnar, AG ;
Lichtsteiner, S ;
Kim, NW ;
Trager, JB ;
Taylor, RD ;
Carlos, R ;
Andrews, WH ;
Wright, WE ;
Shay, JW ;
Harley, CB ;
Morin, GB .
NATURE GENETICS, 1997, 17 (04) :498-502
[73]  
Wong AST, 1999, INT J CANCER, V81, P180
[74]   Direct activation of TERT transcription by c-MYC [J].
Wu, KJ ;
Grandori, C ;
Amacker, M ;
Simon-Vermot, N ;
Polack, A ;
Lingner, J ;
Dalla-Favera, R .
NATURE GENETICS, 1999, 21 (02) :220-224
[75]  
Wymann MP, 1996, MOL CELL BIOL, V16, P1722
[76]   DEVELOPMENTALLY PROGRAMMED HEALING OF CHROMOSOMES BY TELOMERASE IN TETRAHYMENA [J].
YU, GL ;
BLACKBURN, EH .
CELL, 1991, 67 (04) :823-832
[77]   The modulation of membrane structure and stability by dimethyl sulphoxide (Review) [J].
Yu, ZW ;
Quinn, PJ .
MOLECULAR MEMBRANE BIOLOGY, 1998, 15 (02) :59-68
[78]   Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer [J].
Yuan, ZQ ;
Sun, M ;
Feldman, RI ;
Wang, G ;
Ma, XL ;
Jiang, C ;
Coppola, D ;
Nicosia, SV ;
Cheng, JQ .
ONCOGENE, 2000, 19 (19) :2324-2330
[79]   Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres [J].
Zhu, XD ;
Küster, B ;
Mann, M ;
Petrini, JHJ ;
de Lange, T .
NATURE GENETICS, 2000, 25 (03) :347-352